MAPK3 and pulmonary fibrosis: As shown in Fig. 10b, c, e, marked lung fibrosis, as evidenced by increased picrosirius red staining area and elevated hydroxyproline content, was established both in control and Col1a2-Cre/ERT2*Txndc5fl/f mice 7 days after BLM treatment.